Cite

HARVARD Citation

    Moureau, S. et al. (n.d.). Therapeutic potential of novel PLK1 inhibitor CYC140 in esophageal cancer and acute leukemia. European journal of cancer. pp. S117-. [Online]. 
  
Back to record